Department of Oral and Maxillofacial Surgery, Section Medical-Dental Interaction, Academic Center for Dentistry (ACTA), The Netherlands.
Int J Oral Maxillofac Surg. 2013 Apr;42(4):502-7. doi: 10.1016/j.ijom.2012.09.018. Epub 2012 Nov 2.
The aim was to evaluate the management strategies of Dutch oral and maxillofacial surgeons when performing invasive dental or oral surgery in patients using oral antithrombotic medication (OAM). In November 2009 a survey was mailed to all 213 members of the Dutch Society for Oral and Maxillofacial Surgery. A response rate of 57% was achieved with 79 surveys returned through mail and 38 surveys answered through the Internet. The results show that many different treatment strategies are advocated by Dutch oral and maxillofacial surgeons, regarding preferred international normalised ratio (INR) value and continuation or discontinuation of OAM prior to invasive dental or oral surgery. The risk of bleeding during or after an invasive dental procedure was overestimated. A need for a practice guideline on this topic was expressed by 73% of respondents.
目的在于评估荷兰口腔颌面外科医生在使用口服抗血栓药物（OAM）的患者中进行有创牙科或口腔手术时的管理策略。2009 年 11 月，向荷兰口腔颌面外科学会的 213 名成员邮寄了一份调查问卷。通过邮件收到了 79 份回复，通过互联网收到了 38 份回复，回复率为 57%。结果表明，荷兰口腔颌面外科医生针对侵入性牙科或口腔手术前 OAM 的首选国际标准化比值（INR）值和继续或停止使用存在许多不同的治疗策略。手术过程中和手术后出血的风险被高估了。73%的受访者表示需要制定该主题的实践指南。
